Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_10218 | 4 | 0.08 | Mlig455_048460 | Neo: - Age: - |
Mlig455_048460 {REF} {Length: 476} {NoTransDecoderORF} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10218 | 4 | 0.08 | Mlig455_048460 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_048460 {REF} {Length: 476} {NoTransDecoderORF} | |
2. | MligTC455_25858 | 48 | 1 | Mlig455_005649, Mlig455_005698, Mlig455_008659 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_005649 {REF} {Length: 1060} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=27.0]} {RNA1509_35414} {RNA1310_2501.1} {RNA815_9496.1} Mlig455_005698 {REF} {Length: 1505} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=26.8]} {RNA1509_35414} {RNA1310_2501.1} {RNA815_9496.1} Mlig455_008659 {REF} {Length: 1151} {TRANSSPLICED} {Pfam: haloacid dehalogenase-like hydrolase [PF08282.14, score=19.9]} {RNA1509_25258} {RNA1310_56236} {RNA815_9496.1} |
|
3. | MligTC455_46869 | 20 | 0.41 | Mlig455_054214 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_054214 {REF} {Length: 1474} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.0]} {RNA1310_23944} {RNA815_32018} | |
4. | MligTC455_49958 | 16 | 0.32 | Mlig455_014437, Mlig455_070189 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_014437 {REF} {Length: 921} {RNA1310_45206} {RNA815_28788} Mlig455_070189 {REF} {Length: 739} {RNA1310_45206} {RNA815_28788} |
|
5. | MligTC455_50546 | 21 | 0.44 | Mlig455_045408 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_045408 {REF} {Length: 1345} {RNA1310_102440} | |
6. | MligTC455_56698 | 6 | 0.12 | Mlig455_025020 | Neo: - Age: - |
KIAA1958 | 1 | - | - | - | - | 1.000 | - | Mlig455_025020 {REF} {Length: 662} {Pfam: Domain of unknown function (DUF3504) [PF12012.10, score=44.7]; Phage integrase family [PF00589.24, score=39.5]} {Human: ENSG00000165185, KIAA1958, KIAA1958, [Score=50.8, Expect=6e-07]} {Mouse: ENSMUSG00000045071, E130308A19Rik, RIKEN cDNA E130308A19 gene, [Score=50.8, Expect=4e-07]} {RNA1310_51564} |
7. | MligTC455_08103 | 8 | 0.16 | Mlig455_056829 | Neo: - Age: - |
0.999 | - | - | - | - | 0.999 | - | Mlig455_056829 {REF} {Length: 754} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_24771} {RNA1310_8080} {RNA815_26991} | |
8. | MligTC455_11078 | 15 | 0.31 | Mlig455_045628 | Neo: - Age: - |
0.999 | - | - | - | - | 0.999 | - | Mlig455_045628 {REF} {Length: 2373} {Pfam: Polycystin cation channel [PF08016.14, score=25.4]} {RNA1310_39436.1} {RNA815_35444} | |
9. | MligTC455_13171 | 25 | 0.53 | Mlig455_005963, Mlig455_005967 | Neo: - Age: - |
0.999 | - | - | - | - | 0.999 | - | Mlig455_005963 {REF} {Length: 2617} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} Mlig455_005967 {REF} {Length: 1405} {Pfam: Lectin C-type domain [PF00059.23, score=20.7]} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} |
|
10. | MligTC455_21580 | 101 | 2.11 | Mlig455_032452 | Neo: - Age: - |
WSCD2 | 0.999 | - | - | - | - | 0.999 | - | Mlig455_032452 {REF} {Length: 945} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=3e-07]; ENSG00000179314, WSCD1, WSC domain containing 1, [Score=51.2, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.8, Expect=9e-08]} {RNA1310_78298} {RNA815_49767} |
11. | MligTC455_45032 | 56 | 1.16 | Mlig455_034186 | Neo: - Age: - |
KREMEN1 | 0.999 | - | - | - | - | 0.999 | - | Mlig455_034186 {REF} {Length: 1010} {Pfam: WSC domain [PF01822.21, score=53.3]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.2, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=53.9, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=47.8, Expect=3e-06]} {RNA1310_39474.1} {RNA815_33128} |
12. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 0.999 | - | - | - | - | 0.999 | - | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |
13. | MligTC455_00125 | 9 | 0.19 | Mlig455_050922 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_050922 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_12392} {RNA815_36374} | |
14. | MligTC455_01465 | 6 | 0.12 | Mlig455_025550 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_025550 {REF} {Length: 249} {NoTransDecoderORF} | |
15. | MligTC455_08955 | 4 | 0.07 | Mlig455_065502 | Neo: - Age: Up-Down-Down |
0.998 | - | - | - | - | 0.998 | - | Mlig455_065502 {REF} {Length: 2389} {NoTransDecoderORF} {RNA1509_39003} {RNA1310_16982, RNA1509_39003} {RNA1509_39003, RNA815_58103} | |
16. | MligTC455_14317 | 18 | 0.37 | Mlig455_032329 | Neo: - Age: - Region-enriched R2: 9.341/0.00123 |
0.998 | - | - | - | - | 0.998 | - | Mlig455_032329 {REF} {Length: 1038} {RNA1509_48973} {RNA1310_34931} {RNA815_36286} | |
17. | MligTC455_16144 | 10 | 0.2 | Mlig455_026310 | Neo: - Age: Down-Up-Down |
TMTC3 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_026310 {REF} {Length: 3431} {Pfam: Domain of unknown function (DUF1736) [PF08409.13, score=67.8]; Tetratricopeptide repeat [PF13428.8, score=23.7]} {Human: ENSG00000139324, TMTC3, transmembrane and tetratricopeptide repeat containing 3, [Score=215, Expect=1e-57]} {Mouse: ENSMUSG00000036676, Tmtc3, transmembrane and tetratricopeptide repeat containing 3, [Score=204, Expect=4e-54]; ENSMUSG00000041594, Tmtc4, transmembrane and tetratricopeptide repeat containing 4, [Score=204, Expect=9e-55]} {Dmel: FBgn0020312, CG4050, [Score=197, Expect=6e-52]} {Celegans: WBGene00018175, F38B6.6, Transmembrane and TPR repeat-containing protein F38B6.6, [Score=166, Expect=1e-42]} {Smed: dd_Smed_v6_6940_0_1, dd_Smed_v6_6940_0_1, [Score=186, Expect=8e-49]} {RNA1310_6193.1} {RNA815_10836} |
18. | MligTC455_26253 | 375 | 7.81 | Mlig455_009976 | Neo: - Age: - |
FZD5 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_009976 {REF} {Length: 4082} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=407.2]; Fz domain [PF01392.24, score=99.7]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=605, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=402, Expect=2e-130]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=417, Expect=8e-139]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_25697, RNA1509_59712} {RNA1310_9946, RNA1509_25697} {RNA1509_25697, RNA815_7287} |
19. | MligTC455_28590 | 8 | 0.17 | Mlig455_036217 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_036217 {REF} {Length: 55} {NoTransDecoderORF} {RNA1509_51858} | |
20. | MligTC455_39180 | 256 | 5.34 | Mlig455_057231 | Neo: - Age: logFC(26M/2M)=-0.449 |
TCTE3 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_057231 {REF} {Length: 1057} {Pfam: Tctex-1 family [PF03645.15, score=43.3]} {Human: ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [RH, Score=67.8, Expect=2e-13]} {Mouse: ENSMUSG00000028523, Tctex1d1, Tctex1 domain containing 1, [Score=61.2, Expect=2e-11]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [Score=59.3, Expect=1e-10]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [Score=59.3, Expect=1e-10]; ENSMUSG00000116780, Gm3417, predicted gene 3417, [Score=58.5, Expect=2e-10]} {Smed: dd_Smed_v6_9036_0_1, dd_Smed_v6_9036_0_1, [Score=92.4, Expect=2e-23]} {RNA1509_34873, RNA1509_48552} {RNA1310_34743, RNA1509_34873, RNA1509_48552} {RNA1509_34873, RNA1509_48552, RNA815_18661} |
21. | MligTC455_43663 | 88 | 1.83 | Mlig455_070157 | Neo: - Age: Up-Down-Up |
0.998 | - | - | - | - | 0.998 | - | Mlig455_070157 {REF} {Length: 2611} {RNA1310_65373} {RNA815_37965} | |
22. | MligTC455_49671 | 22 | 0.45 | Mlig455_031821, Mlig455_047620, Mlig455_047673 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_031821 {REF} {Length: 954} {Pfam: WSC domain [PF01822.21, score=56.5]; PAN domain [PF00024.28, score=20.4]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=54.7, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=53.9, Expect=2e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} Mlig455_047620 {REF} {Length: 1341} {Pfam: WSC domain [PF01822.21, score=54.9]; Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=21.1]; PAN domain [PF00024.28, score=19.0]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=55.8, Expect=6e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=54.7, Expect=8e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} Mlig455_047673 {REF} {Length: 1341} {Pfam: WSC domain [PF01822.21, score=54.9]; Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=21.1]; PAN domain [PF00024.28, score=19.0]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=55.8, Expect=6e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=54.7, Expect=8e-08]} {RNA1509_43359} {RNA1310_64325} {RNA815_23776.1} |
|
23. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
0.998 | - | - | - | - | 0.998 | - | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
24. | MligTC455_55037 | 10 | 0.2 | Mlig455_048903 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_048903 {REF} {Length: 570} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_41553} {RNA1310_20523} {RNA815_34173} | |
25. | MligTC455_33812 | 919 | 19.14 | Mlig455_051682 | Neo: - Age: - Region-enriched R2: 3.553/0.00065 |
MOXD1 | 0.997 | - | - | - | - | 0.997 | - | Mlig455_051682 {REF} {Length: 2654} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=93.8]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=68.4]; Proline-rich membrane anchor 1 [PF16101.7, score=18.9]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=120, Expect=2e-28]; ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=117, Expect=2e-27]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=135, Expect=1e-33]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=129, Expect=8e-32]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=139, Expect=2e-35]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=119, Expect=1e-29]} {RNA1509_127, RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801} {RNA1310_9934.2, RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801} {RNA1509_19917, RNA1509_32862, RNA1509_35753, RNA1509_41801, RNA815_4383.1} |
26. | MligTC455_50344 | 24 | 0.51 | Mlig455_054355 | Neo: - Age: - |
0.997 | - | - | - | - | 0.997 | - | Mlig455_054355 {REF} {Length: 1376} {RNA1310_56750} | |
27. | MligTC455_07113 | 8 | 0.16 | Mlig455_058226 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_058226 {REF} {Length: 47} {NoTransDecoderORF} | |
28. | MligTC455_12489 | 22 | 0.45 | Mlig455_004470 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_004470 {REF} {Length: 1368} {Pfam: Lectin C-type domain [PF00059.23, score=24.8]} {RNA1310_22051} {RNA815_28288} | |
29. | MligTC455_13095 | 40 | 0.82 | Mlig455_036239 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130} | |
30. | MligTC455_18322 | 82 | 1.71 | Mlig455_021228 | Neo: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_021228 {REF} {Length: 3954} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=26.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=229, Expect=2e-64]} {RNA1509_9124} {RNA1310_5268.1, RNA1509_9124} {RNA1509_9124, RNA815_1717.1} | |
31. | MligTC455_22446 | 195 | 4.05 | Mlig455_002759, Mlig455_063362 | Neo: - Age: - Region-enriched R2: 4.960/0.00023 |
SLC6A3 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_002759 {REF} {Length: 4906} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=606.3]; Rhomboid family [PF01694.24, score=73.2]} {Human: ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [Score=541, Expect=9e-179]; ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [Score=541, Expect=9e-179]; ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [Score=540, Expect=3e-178]} {Mouse: ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [Score=552, Expect=0.0]; ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [Score=545, Expect=3e-180]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=498, Expect=2e-162]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=446, Expect=9e-143]} {Smed: dd_Smed_v6_22486_0_1, dd_Smed_v6_22486_0_1, [RH, Score=605, Expect=0.0]} {RNA1509_46048} {RNA1310_21784} {RNA815_8613} Mlig455_063362 {REF} {Length: 2875} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=603.8]} {Human: ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [Score=543, Expect=0.0]; ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [Score=543, Expect=0.0]; ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [Score=540, Expect=0.0]} {Mouse: ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [Score=551, Expect=0.0]; ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [Score=549, Expect=0.0]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=494, Expect=4e-167]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=444, Expect=7e-148]} {Smed: dd_Smed_v6_22486_0_1, dd_Smed_v6_22486_0_1, [RH, Score=599, Expect=0.0]} {RNA1509_46048} {RNA1310_21784} {RNA815_8613} |
32. | MligTC455_29508 | 144 | 3 | Mlig455_003167 | Neo: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_003167 {REF} {Length: 1270} {Pfam: Interferon-induced 6-16 family [PF06140.15, score=24.5]} {RNA1509_46297} {RNA1310_35782} {RNA815_17641.2} | |
33. | MligTC455_37792 | 210 | 4.38 | Mlig455_024774 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.926 Region-enriched R2: 6.055/0.00271 |
PKD1L2 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_024774 {REF} {Length: 6374} {Pfam: Polycystin cation channel [PF08016.14, score=224.6]; PLAT/LH2 domain [PF01477.25, score=66.8]; Ion transport protein [PF00520.33, score=30.8]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=179, Expect=9e-45]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=187, Expect=3e-47]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=109, Expect=1e-23]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=187, Expect=2e-47]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=902, Expect=0.0]} {RNA1509_46134} {RNA1310_488} {RNA815_1711} |
34. | MligTC455_48380 | 42 | 0.88 | Mlig455_066957 | Neo: - Age: Up-Down-Up |
CCDC154 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_066957 {REF} {Length: 3248} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=53.1]} {Human: ENSG00000197599, CCDC154, coiled-coil domain containing 154, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000059562, Ccdc154, coiled-coil domain containing 154, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [Score=312, Expect=5e-95]} {RNA1509_14849} {RNA1310_2077.1} {RNA815_10060} |
35. | MligTC455_52176 | 5 | 0.1 | Mlig455_068121 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_068121 {REF} {Length: 1860} {NoTransDecoderORF} {RNA1509_50388} {RNA1310_49576} {RNA815_13228} | |
36. | MligTC455_05907 | 8 | 0.16 | Mlig455_044100 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_044100 {REF} {Length: 485} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_64877} | |
37. | MligTC455_18451 | 118 | 2.46 | Mlig455_031824, Mlig455_047676 | Neo: - Age: - |
WSCD2 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_031824 {REF} {Length: 1015} {Pfam: WSC domain [PF01822.21, score=53.3]; PAN domain [PF00024.28, score=21.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=63.2, Expect=6e-11]} {RNA1509_53783} {RNA1310_58580.1} {RNA815_46263} Mlig455_047676 {REF} {Length: 926} {Pfam: WSC domain [PF01822.21, score=57.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=64.3, Expect=2e-11]} {Mouse: ENSMUSG00000020811, Wscd1, WSC domain containing 1, [Score=49.3, Expect=1e-06]} {RNA1310_58580.1} |
38. | MligTC455_24613 | 18 | 0.37 | Mlig455_005738 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_005738 {REF} {Length: 1416} {Pfam: Lectin C-type domain [PF00059.23, score=20.0]} {RNA1310_35102} {RNA815_16139} | |
39. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
40. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 0.995 | - | - | - | - | 0.995 | - | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
41. | MligTC455_50335 | 2763 | 57.56 | Mlig455_069700 | Neo: - Age: - Region-enriched R2: 4.743/0.00005 |
HBG2 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_069700 {REF} {Length: 1017} {Pfam: Globin [PF00042.24, score=69.5]} {Human: ENSG00000196565, HBG2, hemoglobin subunit gamma 2, [RH, Score=49.7, Expect=8e-08]; ENSG00000284931, AC104389.5, novel protein, [RH, Score=47.4, Expect=7e-07]} {RNA1509_8100} {RNA1310_38363} {RNA815_18105} |
42. | MligTC455_55959 | 8 | 0.16 | Mlig455_033037 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_033037 {REF} {Length: 278} {NoTransDecoderORF} {RNA1310_64877} | |
43. | MligTC455_00998 | 9 | 0.18 | Mlig455_051254, Mlig455_051271 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_051254 {REF} {Length: 766} {RNA1509_42786} {RNA1310_55169} {RNA815_23925} Mlig455_051271 {REF} {Length: 410} {NoTransDecoderORF} |
|
44. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
45. | MligTC455_07334 | 7 | 0.15 | Mlig455_000992 | Neo: - Age: - |
PLA2G16 | 0.994 | - | - | - | - | 0.994 | - | Mlig455_000992 {REF} {Length: 1190} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=63.5]} {Human: ENSG00000176485, PLA2G16, phospholipase A2 group XVI, [RH, Score=56.2, Expect=2e-09]} {Mouse: ENSMUSG00000060675, Pla2g16, phospholipase A2, group XVI, [Score=53.5, Expect=1e-08]; ENSMUSG00000022525, Hrasls, HRAS-like suppressor, [Score=53.5, Expect=9e-09]} {RNA1310_36500.1} {RNA815_19807} |
46. | MligTC455_11229 | 51 | 1.06 | Mlig455_054212 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_054212 {REF} {Length: 1481} {RNA1310_23944} {RNA815_32018} | |
47. | MligTC455_15661 | 322 | 6.72 | Mlig455_000589 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.500/0.00231 |
NR2E1 | 0.994 | - | - | - | - | 0.994 | - | Mlig455_000589 {REF} {Length: 2434} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=97.6]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=73.9]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=188, Expect=2e-53]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=188, Expect=1e-53]} {Dmel: FBgn0003720, tll, tailless, [RH, Score=202, Expect=2e-58]} {Celegans: WBGene00003657, nhr-67, Nuclear hormone receptor family member nhr-67, [RH, Score=193, Expect=3e-55]} {Smed: dd_Smed_v6_21347_0_1, dd_Smed_v6_21347_0_1, [RH, Score=188, Expect=9e-54]} {RNA1509_39776} {RNA1310_21550, RNA1509_39776} {RNA1509_39776, RNA815_27099.1} |
48. | MligTC455_18909 | 14 | 0.29 | Mlig455_033525 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_033525 {REF} {Length: 1169} {RNA1310_56722} {RNA815_26444} | |
49. | MligTC455_18910 | 7 | 0.14 | Mlig455_069210 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_069210 {REF} {Length: 1153} {RNA1310_43536} {RNA815_26444} | |
50. | MligTC455_19455 | 23 | 0.48 | Mlig455_059587 | Neo: - Age: Up-Down-Down |
0.994 | - | - | - | - | 0.994 | - | Mlig455_059587 {REF} {Length: 1356} {Pfam: FAM216B protein family [PF15107.8, score=21.6]} {RNA1310_31687} {RNA815_40824} | |
51. | MligTC455_33495 | 28 | 0.58 | Mlig455_047292, Mlig455_047342, Mlig455_069323 | Neo: - Age: - |
LHFPL2 | 0.994 | - | - | - | - | 0.994 | - | Mlig455_047292 {REF} {Length: 1105} {RNA1310_118047} Mlig455_047342 {REF} {Length: 1735} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=104.8]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=30.7]} {Human: ENSG00000145685, LHFPL2, LHFPL tetraspan subfamily member 2, [Score=47.8, Expect=1e-05]} {Mouse: ENSMUSG00000045312, Lhfpl2, lipoma HMGIC fusion partner-like 2, [Score=47.0, Expect=1e-05]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=175, Expect=1e-51]} {RNA1509_30020} {RNA1310_118047} {RNA815_5159.1} Mlig455_069323 {REF} {Length: 886} {RNA1310_118047} |
52. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 0.994 | - | - | - | - | 0.994 | - | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
53. | MligTC455_36720 | 17 | 0.35 | Mlig455_044939 | Neo: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_044939 {REF} {Length: 1691} {RNA1509_27766} {RNA1310_69132} {RNA815_11337} | |
54. | MligTC455_39874 | 143 | 2.98 | Mlig455_049425 | Neo: - Age: - |
PKDCC | 0.994 | - | - | - | - | 0.994 | - | Mlig455_049425 {REF} {Length: 3789} {Pfam: Protein-kinase domain of FAM69 [PF12260.10, score=30.6]; Protein kinase domain [PF00069.27, score=21.0]} {Human: ENSG00000162878, PKDCC, protein kinase domain containing, cytoplasmic, [RH, Score=192, Expect=4e-55]} {Mouse: ENSMUSG00000024247, Pkdcc, protein kinase domain containing, cytoplasmic, [RH, Score=180, Expect=9e-51]} {RNA1310_12305} {RNA815_19030.1} |
55. | MligTC455_53049 | 15 | 0.32 | Mlig455_027996 | Neo: - Age: - |
COL6A5 | 0.994 | - | - | - | - | 0.994 | - | Mlig455_027996 {REF} {Length: 1239} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=47.1]} {Human: ENSG00000172752, COL6A5, collagen type VI alpha 5 chain, [Score=56.6, Expect=2e-08]} {Mouse: ENSMUSG00000025650, Col7a1, collagen, type VII, alpha 1, [Score=53.1, Expect=1e-07]} {Dmel: FBgn0000299, Col4a1, Collagen type IV alpha 1, [Score=47.0, Expect=1e-05]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=58.5, Expect=1e-09]} {RNA1310_72965} {RNA815_62741} |
56. | MligTC455_56570 | 7 | 0.15 | Mlig455_001073 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_001073 {REF} {Length: 237} {NoTransDecoderORF} {RNA1509_2515} {RNA1310_92588} {RNA815_36493} | |
57. | MligTC455_00763 | 8 | 0.18 | Mlig455_066990 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_066990 {REF} {Length: 312} {NoTransDecoderORF} | |
58. | MligTC455_06218 | 21 | 0.44 | Mlig455_036293 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_036293 {REF} {Length: 279} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_11603} {RNA1310_81119} {RNA815_41781} | |
59. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
60. | MligTC455_17088 | 56 | 1.16 | Mlig455_022778 | Neo: - Age: logFC(26M/2M)=-0.737 |
0.993 | - | - | - | - | 0.993 | - | Mlig455_022778 {REF} {Length: 2080} {RNA1509_56619} {RNA1310_21133.1} {RNA815_8631.1} | |
61. | MligTC455_18911 | 10 | 0.21 | Mlig455_003995 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_003995 {REF} {Length: 1473} {Pfam: F5/8 type C domain [PF00754.27, score=28.7]} {RNA1509_32267} {RNA1310_43457} {RNA815_19080.1} | |
62. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
63. | MligTC455_30323 | 14 | 0.29 | Mlig455_033982 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_033982 {REF} {Length: 1701} {Pfam: Zinc knuckle [PF00098.25, score=21.6]} {RNA1509_29299} {RNA1310_6073.2} {RNA815_6982} | |
64. | MligTC455_37931 | 21 | 0.43 | Mlig455_066138 | Neo: - Age: - Region-enriched R5: 3.782/0.00367 |
0.993 | - | - | - | - | 0.993 | - | Mlig455_066138 {REF} {Length: 1150} {RNA1310_52641} {RNA815_21346} | |
65. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
66. | MligTC455_14955 | 12 | 0.25 | Mlig455_058159 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_058159 {REF} {Length: 510} {NoTransDecoderORF} {RNA1310_122094} | |
67. | MligTC455_18323 | 168 | 3.5 | Mlig455_021183, Mlig455_057885 | Neo: - Age: logFC(26M/2M)=-0.384 Region-enriched R2: 3.394/0.02680 |
0.992 | - | - | - | - | 0.992 | - | Mlig455_021183 {REF} {Length: 3969} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=24.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=221, Expect=7e-62]} {RNA1509_9124} {RNA1310_5268.1} {RNA815_1717.1} Mlig455_057885 {REF} {Length: 4416} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=24.3]} {Smed: dd_Smed_v6_11972_0_1, dd_Smed_v6_11972_0_1, [RH, Score=221, Expect=1e-61]} {RNA1509_9124} {RNA1310_5268.1} {RNA815_1717.1} |
|
68. | MligTC455_19322 | 47 | 0.98 | Mlig455_060292 | Neo: - Age: - Region-enriched R5: 4.828/0.04092 |
0.992 | - | - | - | - | 0.992 | - | Mlig455_060292 {REF} {Length: 1265} {RNA1310_61465} {RNA815_19768} | |
69. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
70. | MligTC455_45019 | 64 | 1.33 | Mlig455_009383, Mlig455_036937 | Neo: - Age: - |
WSCD2 | 0.992 | - | - | - | - | 0.992 | - | Mlig455_009383 {REF} {Length: 854} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} Mlig455_036937 {REF} {Length: 858} {Pfam: WSC domain [PF01822.21, score=58.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=2e-10]} {RNA1310_43246} {RNA815_43085} |
71. | MligTC455_46895 | 16 | 0.33 | Mlig455_028803 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_028803 {REF} {Length: 1044} {Pfam: Lectin C-type domain [PF00059.23, score=21.4]} {RNA1509_20946} {RNA1310_35520} {RNA815_50428} | |
72. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
0.992 | - | - | - | - | 0.992 | - | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
73. | MligTC455_10633 | 4 | 0.09 | Mlig455_045075 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_045075 {REF} {Length: 1943} {NoTransDecoderORF} {RNA1509_54007} {RNA1310_80274} {RNA815_10062.1} | |
74. | MligTC455_15843 | 5 | 0.1 | Mlig455_056522 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_056522 {REF} {Length: 630} {NoTransDecoderORF} | |
75. | MligTC455_16015 | 85 | 1.78 | Mlig455_057827 | Neo: - Age: - |
SLC6A3 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_057827 {REF} {Length: 3250} {tRNA: Undet(NNN),pseudo, score=20.8} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=587.0]} {Human: ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [Score=520, Expect=2e-177]; ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [Score=520, Expect=2e-177]; ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [Score=506, Expect=5e-172]} {Mouse: ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [Score=523, Expect=1e-178]; ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [Score=513, Expect=6e-175]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=471, Expect=2e-158]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=432, Expect=2e-143]} {Smed: dd_Smed_v6_22486_0_1, dd_Smed_v6_22486_0_1, [Score=573, Expect=0.0]} {RNA1509_41282} {RNA1310_11169} {RNA815_3966} |
76. | MligTC455_35506 | 7 | 0.14 | Mlig455_022857 | Neo: - Age: - |
RDH12 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_022857 {REF} {Length: 4905} {Pfam: short chain dehydrogenase [PF00106.27, score=72.5]; Enoyl-(Acyl carrier protein) reductase [PF13561.8, score=43.0]; KR domain [PF08659.12, score=19.0]} {Human: ENSG00000139988, RDH12, retinol dehydrogenase 12, [Score=117, Expect=2e-31]; ENSG00000072042, RDH11, retinol dehydrogenase 11, [Score=114, Expect=2e-30]} {Mouse: ENSMUSG00000021123, Rdh12, retinol dehydrogenase 12, [Score=120, Expect=8e-33]} {Dmel: FBgn0033205, CG2064, [Score=120, Expect=3e-33]} {Celegans: WBGene00000971, dhs-7, DeHydrogenases, Short chain, [Score=87.8, Expect=7e-21]} {Smed: dd_Smed_v6_2096_0_1, dd_Smed_v6_2096_0_1, [Score=118, Expect=2e-32]} {RNA1509_36426} {RNA1310_5545, RNA1509_36426} {RNA1509_36426, RNA815_17016} |
77. | MligTC455_43690 | 262 | 5.46 | Mlig455_035029, Mlig455_053437 | Neo: - Age: - Region-enriched R2: 6.108/0.00708 |
WSCD2 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_035029 {REF} {Length: 893} {Pfam: WSC domain [PF01822.21, score=50.2]; PAN domain [PF00024.28, score=29.7]} {RNA1310_42429} {RNA815_24291.1} Mlig455_053437 {REF} {Length: 972} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=29.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=44.7, Expect=1e-05]} {RNA1310_42429} {RNA815_24291.1} |
78. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 0.991 | - | - | - | - | 0.991 | - | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
79. | MligTC455_09977 | 5 | 0.1 | Mlig455_007689 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_007689 {REF} {Length: 1561} {Pfam: Glycine rich protein [PF12810.9, score=32.9]} {RNA1310_129878} | |
80. | MligTC455_10787 | 46 | 0.96 | Mlig455_052810 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_052810 {REF} {Length: 1287} {Pfam: F5/8 type C domain [PF00754.27, score=21.9]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=56.2, Expect=2e-09]} {RNA1509_47815} {RNA1310_114361} {RNA815_11379} | |
81. | MligTC455_13885 | 28 | 0.58 | Mlig455_020919 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_020919 {REF} {Length: 1208} {RNA1310_25040.4} {RNA815_12562.1} | |
82. | MligTC455_21415 | 38 | 0.78 | Mlig455_030394, Mlig455_069019 | Neo: - Age: Up-Down-Down |
SCN5A | 0.99 | - | - | - | - | 0.990 | - | Mlig455_030394 {REF} {Length: 6394} {Pfam: Ion transport protein [PF00520.33, score=542.0]; Polycystin cation channel [PF08016.14, score=81.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=26.0]} {Human: ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [RH, Score=944, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [RH, Score=942, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [RH, Score=932, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [RH, Score=924, Expect=0.0]} {Dmel: FBgn0085434, NaCP60E, Na channel protein 60E, [RH, Score=896, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=322, Expect=2e-90]} {Smed: dd_Smed_v6_12243_0_1, dd_Smed_v6_12243_0_1, [Score=1238, Expect=0.0]} {RNA1509_26911} {RNA1310_25124} {RNA815_23541} Mlig455_069019 {REF} {Length: 6623} {Pfam: Ion transport protein [PF00520.33, score=774.7]; Polycystin cation channel [PF08016.14, score=76.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=25.2]} {Human: ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [RH, Score=1268, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [RH, Score=1214, Expect=0.0]} {Mouse: ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [RH, Score=1276, Expect=0.0]} {Dmel: FBgn0085434, NaCP60E, Na channel protein 60E, [RH, Score=899, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=322, Expect=9e-89]} {Smed: dd_Smed_v6_12243_0_1, dd_Smed_v6_12243_0_1, [Score=1233, Expect=0.0]} {RNA1509_26911} {RNA1310_25124} {RNA815_23541} |
83. | MligTC455_24716 | 8 | 0.17 | Mlig455_059952 | Neo: - Age: Down-Up-Down |
MARCH8 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_059952 {REF} {Length: 2107} {TRANSSPLICED} {Pfam: RING-variant domain [PF12906.9, score=56.5]} {Human: ENSG00000165406, MARCH8, membrane associated ring-CH-type finger 8, [RH, Score=226, Expect=7e-69]; ENSG00000145416, MARCH1, membrane associated ring-CH-type finger 1, [RH, Score=223, Expect=5e-68]; ENSG00000278545, MARCH8, membrane associated ring-CH-type finger 8, [RH, Score=220, Expect=3e-70]} {Mouse: ENSMUSG00000025702, March8, membrane-associated ring finger (C3HC4) 8, [RH, Score=228, Expect=4e-73]; ENSMUSG00000036469, March1, membrane-associated ring finger (C3HC4) 1, [RH, Score=226, Expect=6e-72]} {Dmel: FBgn0035983, CG4080, [RH, Score=222, Expect=5e-67]} {Celegans: WBGene00007643, marc-3, MARCH (Membrane-Associated Ring finger (C3HC4)) homolog, [RH, Score=67.8, Expect=2e-12]} {Smed: dd_Smed_v6_4997_0_2, dd_Smed_v6_4997_0_2, [RH, Score=244, Expect=7e-78]} {RNA1509_23175} {RNA1310_20001, RNA1509_23175} {RNA1509_23175, RNA815_11300} |
84. | MligTC455_26865 | 106 | 2.21 | Mlig455_010142 | Neo: - Age: - |
SEL1L3 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_010142 {REF} {Length: 3200} {Pfam: Sel1 repeat [PF08238.14, score=37.9]; Tetratricopeptide repeat [PF13176.8, score=18.5]} {Human: ENSG00000091490, SEL1L3, SEL1L family member 3, [Score=225, Expect=7e-62]} {Mouse: ENSMUSG00000029189, Sel1l3, sel-1 suppressor of lin-12-like 3 (C. elegans), [Score=230, Expect=2e-63]} {Dmel: FBgn0028475, Hrd3, HMG-coA reductase degradation 3, [Score=82.0, Expect=1e-15]} {Celegans: WBGene00004759, sel-1, SEL-1; Suppressor/Enhancer of Lin-12, [Score=84.7, Expect=1e-16]} {Smed: dd_Smed_v6_7527_0_2, dd_Smed_v6_7527_0_2, [Score=336, Expect=9e-102]} {RNA1509_21264} {RNA1310_3921} {RNA815_11098} |
85. | MligTC455_44442 | 1201 | 25.03 | Mlig455_003131 | Neo: - Age: logFC(26M/2M)=-0.363 |
0.99 | - | - | - | - | 0.990 | - | Mlig455_003131 {REF} {Length: 1831} {RNA1509_26624, RNA1509_27545, RNA1509_31759, RNA1509_3524, RNA1509_42258, RNA1509_44854} {RNA1310_10649.1, RNA1509_26624, RNA1509_27545, RNA1509_31759, RNA1509_42258, RNA1509_44854} {RNA1509_26624, RNA1509_27545, RNA1509_31759, RNA1509_42258, RNA1509_44854, RNA815_4791.2} | |
86. | MligTC455_48364 | 9 | 0.2 | Mlig455_044009 | Neo: - Age: - |
LPAR1 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_044009 {REF} {Length: 2040} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=50.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.9]; Srg family chemoreceptor [PF02118.23, score=20.9]; Serpentine type 7TM GPCR receptor class ab chemoreceptor [PF10292.11, score=20.7]; Frizzled/Smoothened family membrane region [PF01534.19, score=18.7]} {Human: ENSG00000198121, LPAR1, lysophosphatidic acid receptor 1, [Score=48.9, Expect=9e-06]} |
87. | MligTC455_57492 | 5 | 0.11 | Mlig455_009856 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_009856 {REF} {Length: 218} {NoTransDecoderORF} {RNA1310_100871} | |
88. | MligTC455_16060 | 22 | 0.47 | Mlig455_044243 | Neo: - Age: Down-Up-Down |
CFAP157 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_044243 {REF} {Length: 2694} {TRANSSPLICED} {Pfam: Siphovirus Gp157 [PF05565.13, score=20.7]; Protein of unknown function, DUF573 [PF04504.16, score=20.6]} {Human: ENSG00000160401, CFAP157, cilia and flagella associated protein 157, [Score=106, Expect=5e-24]} {Mouse: ENSMUSG00000038987, Cfap157, cilia and flagella associated protein 157, [Score=110, Expect=3e-25]} {Dmel: FBgn0036962, CG17122, [Score=67.8, Expect=1e-11]} {Smed: dd_Smed_v6_11523_0_1, dd_Smed_v6_11523_0_1, [Score=60.8, Expect=1e-09]} {RNA1509_42697} {RNA1310_10711, RNA1509_42697} {RNA1509_42697, RNA815_24261} |
89. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
90. | MligTC455_50740 | 262 | 5.46 | Mlig455_028088 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.630/0.00016 |
SFRP5 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_028088 {REF} {Length: 2548} {Pfam: Fz domain [PF01392.24, score=93.7]} {Human: ENSG00000120057, SFRP5, secreted frizzled related protein 5, [RH, Score=158, Expect=5e-44]} {Mouse: ENSMUSG00000018822, Sfrp5, secreted frizzled-related sequence protein 5, [RH, Score=156, Expect=2e-43]} {Dmel: FBgn0027342, fz4, frizzled 4, [Score=100, Expect=4e-22]} {Celegans: WBGene00022242, sfrp-1, Secreted Frizzled-Related Protein, [RH, Score=163, Expect=2e-46]} {Smed: dd_Smed_v6_13985_0_1, dd_Smed_v6_13985_0_1, [RH, Score=164, Expect=2e-46]} {RNA1509_19129} {RNA1310_15120} {RNA815_30861} |
91. | MligTC455_05742 | 7 | 0.14 | Mlig455_008540 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_008540 {REF} {Length: 294} {NoTransDecoderORF} | |
92. | MligTC455_08166 | 7 | 0.14 | Mlig455_050711 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_050711 {REF} {Length: 4129} {Pfam: F5/8 type C domain [PF00754.27, score=29.9]} {Mouse: ENSMUSG00000030605, Mfge8, milk fat globule-EGF factor 8 protein, [Score=52.4, Expect=2e-06]} {RNA1509_36495} {RNA1310_29817} {RNA815_14414} | |
93. | MligTC455_12445 | 32 | 0.67 | Mlig455_044145 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_044145 {REF} {Length: 1958} {RNA1509_44592} {RNA1310_51055} {RNA815_62885} | |
94. | MligTC455_19042 | 3679 | 76.64 | Mlig455_030661 | Neo: - Age: logFC(26M/2M)=0.480 Region-specific R2: 2.811 Region-enriched R2: 1.755/0.00003 |
CAV1 | 0.988 | - | - | - | - | 0.988 | - | Mlig455_030661 {REF} {Length: 1257} {Pfam: Caveolin [PF01146.19, score=124.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=105, Expect=2e-29]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=105, Expect=2e-29]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [RH, Score=81.6, Expect=8e-20]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=144, Expect=1e-45]} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1310_31540, RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522, RNA815_14585} |
95. | MligTC455_45627 | 651 | 13.56 | Mlig455_061482 | Neo: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_061482 {REF} {Length: 1575} {TRANSSPLICED} {RNA1509_20102, RNA1509_52016, RNA1509_54334} {RNA1310_14542, RNA1509_20102, RNA1509_52016, RNA1509_54334} {RNA1509_20102, RNA1509_52016, RNA1509_54334, RNA815_8538.2} | |
96. | MligTC455_49490 | 48 | 1 | Mlig455_054769 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_054769 {REF} {Length: 1663} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
97. | MligTC455_50334 | 4713 | 98.19 | Mlig455_047582 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.063/0.00049 |
0.988 | - | - | - | - | 0.988 | - | Mlig455_047582 {REF} {Length: 1011} {Pfam: Globin [PF00042.24, score=71.0]} {Smed: dd_Smed_v6_2237_0_1, dd_Smed_v6_2237_0_1, [RH, Score=59.7, Expect=6e-12]} {RNA1509_8100} {RNA1310_38363} {RNA815_18105} | |
98. | MligTC455_52458 | 63 | 1.3 | Mlig455_059320 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_059320 {REF} {Length: 1622} {Pfam: Universal stress protein family [PF00582.28, score=92.6]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=97.4, Expect=1e-26]} {RNA1509_15153} {RNA1310_55094} {RNA815_23718.1} | |
99. | MligTC455_08037 | 13 | 0.27 | Mlig455_037418, Mlig455_037484 | Neo: - Age: - |
CHRNB2, HTR3E | 0.987 | - | - | - | - | 0.987 | - | Mlig455_037418 {REF} {Length: 1268} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=129, Expect=3e-32]; ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=128, Expect=3e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=2e-31]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=126, Expect=2e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=4e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=124, Expect=7e-31]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=123, Expect=3e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=5e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=6e-32]; ENSMUSG00000041189, Chrnb1, cholinergic receptor, nicotinic, beta polypeptide 1 (muscle), [Score=124, Expect=1e-30]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=137, Expect=3e-35]} {Celegans: WBGene00017580, lgc-4, Ligand-gated ion channel 4, [Score=142, Expect=1e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=134, Expect=2e-34]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} Mlig455_037484 {REF} {Length: 1840} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=129, Expect=9e-33]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=127, Expect=7e-32]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=127, Expect=7e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=9e-31]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=4e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=1e-31]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=135, Expect=1e-34]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=137, Expect=5e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=130, Expect=2e-33]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} |
100. | MligTC455_09697 | 52 | 1.08 | Mlig455_009478, Mlig455_061921 | Neo: - Age: - |
CD207 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_009478 {REF} {Length: 1068} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Human: ENSG00000116031, CD207, CD207 molecule, [Score=48.5, Expect=5e-06]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=1e-13]} {RNA1310_33496.1} {RNA815_23317} Mlig455_061921 {REF} {Length: 776} {Pfam: Lectin C-type domain [PF00059.23, score=35.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_33496.1} {RNA815_23317} |